Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
60M
-
Shares change
-
+3.27M
-
Total reported value, excl. options
-
$223M
-
Value change
-
+$12.2M
-
Put/Call ratio
-
0.91
-
Number of buys
-
58
-
Number of sells
-
-20
-
Price
-
$3.71
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2015
99 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q2 2015.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60M shares
.
Largest 10 shareholders include STATE STREET CORP (8.38M shares), BAKER BROS. ADVISORS LP (6.97M shares), Broadfin Capital, LLC (5.66M shares), PUTNAM INVESTMENTS LLC (5.51M shares), FMR LLC (4.58M shares), VANGUARD GROUP INC (3.21M shares), NATIXIS (3.15M shares), BlackRock Fund Advisors (2.25M shares), JENNISON ASSOCIATES LLC (2.16M shares), and DEUTSCHE BANK AG\ (2.08M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.